AI English summary of an SEC filing — figures as filed
GE Aerospace GEGE Aerospace said total revenues for the 3 months ended September 30, 2024 rose $0.5 billion to $9.8 billion, and profit grew $1.6 billion to $1.9 billion, with a margin of 19.2%.
Key points
AI summaryGE Aerospace said total revenues for the 3 months ended September 30, 2024 rose $0.5 billion to $9.8 billion, and profit grew $1.6 billion to $1.9 billion, with a margin of 19.2%.
The company cited higher gains on retained and sold ownership interests in GE HealthCare and AerCap of $1.5 billion, higher gains on sales of business interests of $0.4 billion and higher segment profit of $0.2 billion as drivers of the increase in profit for Q3. It said these were partly offset by higher restructuring and other costs of $0.3 billion and a goodwill impairment loss of $0.3 billion related to Colibrium Additive.
The company said cash flows from operating activities (CFOA) were $4.5 billion ($3.4 billion in the prior-year period) and free cash flows (FCF) were $4.6 billion ($3.5 billion in the prior-year period) for the 9 months ended September 30, 2024. It cited higher net income and lower income tax payments as factors behind the increase, and said working capital growth partly offset them.
The company said it reached an agreement in principle on October 2024 to settle the Hachem case (also known as the Sjunde AP-Fonden case) with the plaintiffs for $362.5 million. The final settlement is subject to court approval.
Key figures
Quarter ended September 30, 2024
- Revenue
- $9.8B
- Net income
- $1.9B
- EPS
- $1.70
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q3 2024 Revenue and Profit Changes
GE Aerospace said total revenues for the 3 months ended September 30, 2024 rose $0.5 billion to $9.8 billion, and profit grew $1.6 billion to $1.9 billion, with a margin of 19.2%.
Source · Based on the MD&A text of the filing
Company Explanation of Q3 Profit Increase
The company cited higher gains on retained and sold ownership interests in GE HealthCare and AerCap of $1.5 billion, higher gains on sales of business interests of $0.4 billion and higher segment profit of $0.2 billion as drivers of the increase in profit for Q3. It said these were partly offset by higher restructuring and other costs of $0.3 billion and a goodwill impairment loss of $0.3 billion related to Colibrium Additive.
Source · Based on the MD&A text of the filing
9-Month Operating and Free Cash Flows
The company said cash flows from operating activities (CFOA) were $4.5 billion ($3.4 billion in the prior-year period) and free cash flows (FCF) were $4.6 billion ($3.5 billion in the prior-year period) for the 9 months ended September 30, 2024. It cited higher net income and lower income tax payments as factors behind the increase, and said working capital growth partly offset them.
Source · Based on the MD&A text of the filing
Hachem Shareholder Class Action Settlement
The company said it reached an agreement in principle on October 2024 to settle the Hachem case (also known as the Sjunde AP-Fonden case) with the plaintiffs for $362.5 million. The final settlement is subject to court approval.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…